Terumo Corporation is a global leader in medical technology, specializing in the development and manufacturing of medical devices and equipment. The company serves healthcare providers, hospitals, and clinics worldwide, focusing on cardiovascular health, blood management, and interventional systems. Terumo operates in various markets including Japan, North America, South America, Europe, the Middle East, Africa, Greater China, and the Asia-Pacific region. Its business model revolves around the production and sale of high-quality medical devices, which generate revenue through direct sales, partnerships, and long-term contracts with healthcare institutions. Terumo's product portfolio includes drug-eluting stents, glucose monitors, vascular grafts, and endovascular devices, among others. The company is committed to sustainability and actively contributes to global health initiatives, such as COVID-19 pandemic relief efforts.

Keywords: medical devices, cardiovascular health, blood management, interventional systems, drug-eluting stents, glucose monitors, vascular grafts, endovascular devices, global healthcare, sustainability.